Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)

Market Cap	8.58B
Revenue (ttm)	2.37B
Net Income (ttm)	247.22M
Shares Out	210.96M
EPS (ttm)	1.18
PE Ratio	34.48
Forward PE	34.37
Dividend	0.19 (0.47%)
Ex-Dividend Date	Oct 25, 2024

Volume	4,520,620
Average Volume	3,230,775
Open	41.00
Previous Close	39.65
Day's Range	40.23 - 41.80
52-Week Range	17.94 - 48.39
Beta	0.59
RSI	59.11
Earnings Date	Apr 30, 2025

About SHA:688131

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 3,576
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688131

Financial Performance

In 2024, SHA:688131's revenue was 2.27 billion, an increase of 20.75% compared to the previous year's 1.88 billion. Earnings were 201.59 million, an increase of 58.17%.